Vanguard Group’s Carisma Therapeutics CARM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $137K | Sell |
|
|||||
|
2025
Q1 | $433K | Sell |
|
|||||
|
2024
Q4 | $594K | Sell |
|
|||||
|
2024
Q3 | $1.42M | Hold |
|
|||||
|
2024
Q2 | $2.2M | Sell |
|
|||||
|
2024
Q1 | $3.59M | Buy |
|
|||||
|
2023
Q4 | $4.6M | Buy |
|
|||||
|
2023
Q3 | $6.6M | Buy |
|
|||||
|
2023
Q2 | $13.2M | Buy |
|
|||||
|
2023
Q1 | $1.75M | Buy |
|
|||||
|
2022
Q4 | $6.62M | Buy |
|
|||||
|
2022
Q3 | $4.61M | Buy |
|
|||||
|
2022
Q2 | $8.71M | Sell |
|
|||||
|
2022
Q1 | $7.65M | Buy |
|
|||||
|
2021
Q4 | $10.1M | Buy |
|
|||||
|
2021
Q3 | $8.09M | Buy |
|
|||||
|
2021
Q2 | $39.3M | Buy |
|
|||||
|
2021
Q1 | $18.7M | Buy |
|
|||||
|
2020
Q4 | $7.96M | Buy |
|
|||||
|
2020
Q3 | $6.58M | Buy |
|
|||||
|
2020
Q2 | $2.88M | Sell |
|
|||||
|
2020
Q1 | $2.24M | Hold |
|
|||||
|
2019
Q4 | $4.16M | Buy |
|
|||||
|
2019
Q3 | $4.49M | Buy |
|
|||||
|
2019
Q2 | $5.33M | Buy |
|
|||||
|
2019
Q1 | $3.64M | Buy |
|
|||||
|
2018
Q4 | $3.83M | Buy |
|
|||||
|
2018
Q3 | $5.42M | Buy |
|
|||||
|
2018
Q2 | $4.03M | Buy |
|
|||||
|
2018
Q1 | $459K | Buy |
|
|||||
|
2017
Q4 | $265K | Buy |
|
|||||
|
2017
Q3 | $291K | Sell |
|
|||||
|
2017
Q2 | $324K | Buy |
|
|||||
|
2017
Q1 | $386K | Buy |
|
|||||
|
2016
Q4 | $231K | Buy |
|
|||||
|
2016
Q3 | $319K | Buy |
|
|||||
|
2016
Q2 | $130K | Hold |
|
|||||
|
2016
Q1 | $25K | Sell |
|
|||||
|
2015
Q4 | $614K | Buy |
|
|||||
|
2015
Q3 | $462K | Buy |
|
|||||
|
2015
Q2 | $318K | Buy |
|
|||||
|
2015
Q1 | $908K | Buy |
|
|||||
|
2014
Q4 | $1.13M | Buy |
|
|||||
|
2014
Q3 | $1.05M | Buy |
|
|||||
|
2014
Q2 | $1.14M | Sell |
|
|||||
|
2014
Q1 | $1.41M | Buy |
|